Diego Barba

Diego Barba

Auto-generated profile, based on publicly available information

Diego Barba

Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
DBDiego Barba
Diego Barba
ALAriana León-Sosa
Ariana León-Sosa
PLPaulina Lugo
Paulina Lugo
DSDaniela Suquillo
Daniela Suquillo
FTFernando Torres
Fernando Torres
Andrés CaicedoAndrés Caicedo
Andrés Caicedo

28 June 2019 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
Francisco Javier Cabrera AFrancisco Javier Cabrera A
Francisco Javier Cabrera A
MOMayra Ortega
Mayra Ortega
FVFrancesca Velarde
Francesca Velarde
EPEliseo Parra
Eliseo Parra
SGStephany Gallardo
Stephany Gallardo
Andrés CaicedoAndrés Caicedo
Andrés Caicedo
Artificial Mitochondrial Transfer or Transplant (AMT/T) can be used to reduce the stress and loss of viability of damaged cells. In MitoCeption, a type of AMT/T, the isolated mitochondria and recipient cells are centrifuged together at 4 °C and then co-incubated at 37 °C in normal culture conditions, inducing the transfer. Ultraviolet radiation (UVR) can affect mitochondria and other cell structures, resulting in tissue stress, aging, and immunosuppression. AMT/T could be used to repair UVR cellular and mitochondrial damage. We studied if a mitochondrial mix from different donors (Primary Allogeneic Mitochondrial Mix, PAMM) can repair UVR damage and promote cell survival. Using a simplified adaption of the MitoCeption protocol, we used peripheral blood mononuclear cells (PBMCs) as the recipient cell model of the PAMM in order to determine if this protocol could repair UVR damage. Our results showed that when PBMCs are exposed to UVR, there is a decrease in metabolic activity, mitochondrial mass, and mtDNA sequence stability as well as an increase in p53 expression and the percentage of dead cells. When PAMM MitoCeption was used on UVR-damaged cells, it successfully transferred mitochondria from different donors to distinct PBMCs populations and repaired the observed UVR damage. Our results represent an advancement in the applications of MitoCeption and other AMT/T. We showed that PBMCs could be used as a PAMM source of mitochondria. We also showed that these mitochondria can be transferred in a mix from different donors (PAMM) to UVR-damaged, non-adherent primary cells. Additionally, we decreased the duration of the MitoCeption protocol.

19 December 2022 in Cytotherapy
Verified
Journal Article
Closed access
Andrés CaicedoAndrés Caicedo
Andrés Caicedo
PRPaola Robayo
Paola Robayo
EMEmilia Morales
Emilia Morales
AMAldana Moyano
Aldana Moyano
DBDiego Barba
Diego Barba
TMTatiana Maron-Gutierrez
Tatiana Maron-Gutierrez